These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103. [Solid-phase synthesis and in vitro activity research of tumor-targeting cell-penetrating peptide]. He JW; Li H; Jiang N; Tai Y; Zhang Q; Yang Y; Chen GH Nan Fang Yi Ke Da Xue Xue Bao; 2011 Feb; 31(2):201-4. PubMed ID: 21354893 [TBL] [Abstract][Full Text] [Related]
104. Modern lipid-, carbohydrate-, and peptide-based delivery systems for peptide, vaccine, and gene products. Simerska P; Moyle PM; Toth I Med Res Rev; 2011 Jul; 31(4):520-47. PubMed ID: 20027671 [TBL] [Abstract][Full Text] [Related]
105. Mechanistic aspects of CPP-mediated intracellular drug delivery: relevance of CPP self-assembly. Pujals S; Fernández-Carneado J; López-Iglesias C; Kogan MJ; Giralt E Biochim Biophys Acta; 2006 Mar; 1758(3):264-79. PubMed ID: 16545772 [TBL] [Abstract][Full Text] [Related]
106. Protein transduction revisited: novel insights into the mechanism underlying intracellular delivery of proteins. Edenhofer F Curr Pharm Des; 2008; 14(34):3628-36. PubMed ID: 19075739 [TBL] [Abstract][Full Text] [Related]
107. Cellular delivery of impermeable effector molecules in the form of conjugates with peptides capable of mediating membrane translocation. Fischer PM; Krausz E; Lane DP Bioconjug Chem; 2001; 12(6):825-41. PubMed ID: 11716670 [TBL] [Abstract][Full Text] [Related]
109. Tips and Tools to Understand Direct Membrane Translocation of siRNA-Loaded WRAP-Based Nanoparticles. Deshayes S; Konate K; Vivès E; Boisguérin P Methods Mol Biol; 2022; 2383():475-490. PubMed ID: 34766308 [TBL] [Abstract][Full Text] [Related]
110. Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics. Heitz F; Morris MC; Divita G Br J Pharmacol; 2009 May; 157(2):195-206. PubMed ID: 19309362 [TBL] [Abstract][Full Text] [Related]
111. Challenges and Methods for the Study of CPP Translocation Mechanisms. Walrant A; Illien F; Sagan S; Rodriguez N Methods Mol Biol; 2022; 2383():143-152. PubMed ID: 34766287 [TBL] [Abstract][Full Text] [Related]
112. Bottom-up engineering of peptide cell translocators based on environmentally modulated quadrupole switches. Fernández A; Crespo A; Maddipati S; Scott R ACS Nano; 2008 Jan; 2(1):61-8. PubMed ID: 19206548 [TBL] [Abstract][Full Text] [Related]
113. Elucidating cell-penetrating peptide mechanisms of action for membrane interaction, cellular uptake, and translocation utilizing the hydrophobic counter-anion pyrenebutyrate. Guterstam P; Madani F; Hirose H; Takeuchi T; Futaki S; El Andaloussi S; Gräslund A; Langel U Biochim Biophys Acta; 2009 Dec; 1788(12):2509-17. PubMed ID: 19796627 [TBL] [Abstract][Full Text] [Related]
114. Arginine containing peptides as delivery vectors. Tung CH; Weissleder R Adv Drug Deliv Rev; 2003 Feb; 55(2):281-94. PubMed ID: 12564981 [TBL] [Abstract][Full Text] [Related]
115. Inhibition of regulated cell death by cell-penetrating peptides. Krautwald S; Dewitz C; Fändrich F; Kunzendorf U Cell Mol Life Sci; 2016 Jun; 73(11-12):2269-84. PubMed ID: 27048815 [TBL] [Abstract][Full Text] [Related]
116. Direct cytosolic delivery of polar cargo to cells by spontaneous membrane-translocating peptides. He J; Kauffman WB; Fuselier T; Naveen SK; Voss TG; Hristova K; Wimley WC J Biol Chem; 2013 Oct; 288(41):29974-86. PubMed ID: 23983125 [TBL] [Abstract][Full Text] [Related]
117. [Protein and peptide construction for delivery of oligonucleotides and DNA into the cell]. Pozmogova GE; Knoppe DG Vopr Med Khim; 1998; 44(4):331-7. PubMed ID: 9845919 [TBL] [Abstract][Full Text] [Related]
118. 1988-2018: Thirty years of drug smuggling at the nano scale. Challenges and opportunities of cell-penetrating peptides in biomedical research. Gallo M; Defaus S; Andreu D Arch Biochem Biophys; 2019 Jan; 661():74-86. PubMed ID: 30447207 [TBL] [Abstract][Full Text] [Related]